Although ALT is generally associated with poor outcomes [9,34], a striking exception emerges in glioblastoma (GBM) [35] and chondrosarcoma, two tumor types historically categorized as immune-cold malignancies with limited treatment responsiveness. This evidence concerns the gene GPT and chondrosarcoma.